cancers-logo

Journal Browser

Journal Browser

Announcements

27 May 2025
Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Biomarkers” Section


We are delighted to share some of the editor’s choice articles in the “Cancer Biomarkers” Section that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, a few Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that may be of interest to you.

The list of relevant papers can be seen below:

“Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies”
by Khadija Turabi, Kelsey Klute and Prakash Radhakrishnan
Cancers 2024, 16(13), 2432; https://doi.org/10.3390/cancers16132432
Available online:  https://doi.org/10.3390/cancers16132432

“Unraveling the Regulatory Role of HuR/microRNA Axis in Colorectal Cancer Tumorigenesis”
by Vikas Yadav, Tejveer Singh, Deepika Sharma, Vivek Kumar Garg, Payel Chakraborty, Souvik Ghatak and Shakti Ranjan Satapathy
Cancers 202416(18), 3183; https://doi.org/10.3390/cancers16183183
Available online:  https://doi.org/10.3390/cancers16183183

“Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma”
by Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner et al.
Cancers 2024, 16(15), 2726; https://doi.org/10.3390/cancers16152726
Available online:  https://doi.org/10.3390/cancers16152726

“Transcriptome-Wide Association Study Reveals New Molecular Interactions Associated with Melanoma Pathogenesis”
by Mohamed N. Saad and Mohamed Hamed
Cancers 202416(14), 2517; https://doi.org/10.3390/cancers16142517
Available online:  https://doi.org/10.3390/cancers16142517

“Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome”
by Kate Lacey, Megan R. Greener, Tangkam R. Marak, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Stewart G. Martin and Sarah J. Storr
Cancers 202416(18), 3206; https://doi.org/10.3390/cancers16183206
Available online:  https://doi.org/10.3390/cancers16183206

“Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis Bullosa”
by Hélène Ragot, Sonia Gaucher, Mathilde Bonnet des Claustres, Justine Basset, Rose Boudan, Maxime Battistella, Emmanuelle Bourrat, Alain Hovnanian and Matthias Titeux
Cancers 202416(13), 2476; https://doi.org/10.3390/cancers16132476
Available online:  https://doi.org/10.3390/cancers16132476

Special Issues:

Immune Biomarkers in Solid Tumors: From Peripheral Blood Parameters to Tissue-Based Indicators for Prognosis and Therapy Response
Guest Editors: Dr. Ioannis P. Trontzas and Dr. Konstantinos Syrigos
Submission deadline: 28 April 2026

Diagnosis and Biomarkers for Hematologic Malignancies
Guest Editors:  Dr. Luis Colomo and Prof. Dr. Francesco Lanza
Submission deadline: 31 January 2026

Faulty Ribosome Biogenesis and Cancer: Mechanisms and Therapeutic Perspectives
Guest Editors:  Dr. Paola Bellosta and Dr. Marianna Penzo
Submission deadline: 31 December 2025

Decision-Making Biomarkers in the Treatment of Hepatocellular Carcinoma
Guest Editors:  Dr. Norihiro Imai and Dr. Dongming Liu
Submission deadline: 30 September 2026

You are invited to view and submit relevant papers to Cancers using the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

More News...
Back to TopTop